PRTN3 and rheumatoid arthritis: In a study by van der Ven et al., the predictive value of US for IA development within 1 year was studied in 159 patients with inflammatory arthralgia, without clinical synovitis, but with or without RA-related autoantibodies (ACPA-positive 15%; RF-positive 26.4%) [29].